title: Stereoselective synthesis of (1R,2S,3R)-camphordiamine.
authors.affiliation: Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA. cbusacca@rdg.boehringer-ingelheim.com
authors.forename: C A
authors.initials: CA
authors.lastname: Busacca
authors.forename: S
authors.initials: S
authors.lastname: Campbell
authors.forename: Y
authors.initials: Y
authors.lastname: Dong
authors.forename: D
authors.initials: D
authors.lastname: Grossbach
authors.forename: M
authors.initials: M
authors.lastname: Ridges
authors.forename: L
authors.initials: L
authors.lastname: Smith
authors.forename: E
authors.initials: E
authors.lastname: Spinelli
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry; D002164:Camphor / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000737:chemistry; D003959:Diamines / Q000138:chemical synthesis* / Q000737:chemistry; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D013237:Stereoisomerism
chemical_list: D000970:Antineoplastic Agents; D003959:Diamines; C415332:camphordiamine; D002164:Camphor